Iron therapy in migraine headache
Phase 2
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT201107117004N1
- Lead Sponsor
- Vice chancellor for research, Shahrekord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
inclusion criteria:
?Female Patients having migraine; age between 15 to 45 years;
the first group with negative balance of iron; the second group with iron deficiency; third group with normal level of iron.
(Patients with the following characters will be considered as iron deficiency (MCHC<30g/d,MCV<80fl,Tibc>360µg/dl, MCH<27pg/d,Hb<10g/dl, HCT). Patients with feritin less than 20 microgram in liter will be considered as negative balance of iron.)
Exclusion criteria: Pregnancy, lactation, using psychiatric, OTC or other sexual hormones, having systemic illness such as hypertension, asthma.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of headache attacks. Timepoint: three periods of 15 days. Method of measurement: questionnaire.;Severity of headache attacks. Timepoint: three periods of 15 days. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Ferritin. Timepoint: At the beginning and at the end of the study. Method of measurement: Laboratory methods.;Blood iron. Timepoint: At the beginning and at the end of the study. Method of measurement: laboratory methods.